Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTaking berberine alongside Wegovy is a question that comes up often, and the honest answer is: there is no clinical evidence that the combination is safe or effective, and no UK prescribing guidance supports it. Both compounds affect blood sugar and digestion. Adding berberine to semaglutide treatment without medical supervision carries real risks that are worth understanding before you decide anything. These are prescription-only medicines requiring clinical assessment — a prescriber makes the call on what is appropriate for you individually.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
If you've landed here, you've probably spent some time on nutrition forums or social media where berberine is being stacked with GLP-1 medicines like Wegovy. The framing is appealing: a cheap, natural supplement that supposedly amplifies what semaglutide does. That comparison circulates widely, and it's understandable that it catches people's attention.
Berberine is a compound extracted from several plants, including barberry and goldenseal, and it does have some modest evidence behind it for blood-glucose regulation, enough that researchers have studied it as a potential adjunct in type 2 diabetes management. But the leap from that evidence base to 'stack it with your Wegovy' involves several assumptions the research does not support. The studies on berberine were conducted in people not taking GLP-1 receptor agonists. There is no published clinical trial, and no MHRA-approved guidance, examining what happens when berberine and semaglutide are combined in the same person at the same time.
The NHS medicines guidance on semaglutide outlines a careful, prescriber-led approach to any concurrent medication or supplement, and for good reason. Wegovy is a prescription-only treatment that already produces significant physiological changes; layering an unstudied compound on top of it is not a neutral act. For a broader grounding in how semaglutide works and what it is licensed to do in the UK, the semaglutide overview page covers the full picture.
Semaglutide lowers blood glucose, that is part of how it works in people with type 2 diabetes, and it produces modest blood-sugar reductions even in people without diabetes. Berberine acts on some of the same metabolic pathways, particularly AMPK activation and reduced hepatic glucose output. Take them together and you have two agents working in overlapping ways on blood sugar, without any dose-adjustment designed for that overlap.
The result could be blood glucose falling further than expected. For most people on Wegovy for weight management this may not produce a frank hypoglycaemic episode, but it can cause symptoms (light-headedness, fatigue, shakiness) that are easy to misattribute to the GLP-1 medicine or to hunger. That misattribution matters, because it might lead someone to adjust their Wegovy dose inappropriately rather than identifying the supplement as the variable.
The second risk is digestive. Wegovy slows gastric emptying as part of its mechanism, and berberine independently affects gut motility. The NHS guidance on weight-management injections notes that GLP-1 medicines already carry a gastrointestinal side-effect profile (nausea, reflux, loose stools) that tends to be most pronounced at the start of treatment or after a dose increase. Adding berberine can amplify gut symptoms in ways that make tolerability worse, particularly during those adjustment windows. If you're weighing up other licensed options alongside or instead of semaglutide, it's worth reading about how orlistat compares as an add-on, since that at least has a defined evidence base in the licensed setting.
There is no NICE appraisal of berberine for weight loss. There is no MHRA-licensed indication for berberine as a medicine in the UK. It is sold as a food supplement, which means it is not subject to the same manufacturing standards, consistency checks or interaction-assessment requirements as a licensed medicine. Batch-to-batch potency can vary.
The NHS patient information for semaglutide advises telling your prescriber or pharmacist about all supplements and herbal products you take, precisely because interactions are possible even with substances that feel low-risk. That advice exists for a reason. A prescriber who knows you are considering berberine can assess your full picture (your current dose, your blood glucose trends, any other medications) before making a recommendation rather than after a problem has appeared. You can explore the detail of how berberine and Wegovy interact on our dedicated page, or read a closer look at the practicalities of taking the two together.
Thinking about starting Wegovy through a regulated private route? Our prescribers review every consultation personally, start your free consultation and they will go through your full medication and supplement list as part of that process.
This is the question many people actually want answered. If you are already taking berberine and have been prescribed Wegovy, or are about to start it, the right step is to tell your prescriber before your first dose, not to make that decision alone. The same applies in reverse: if you are established on Wegovy and are thinking about adding berberine, speak to your prescriber first.
In practice, many clinicians will advise stopping the supplement before beginning treatment, simply to remove a variable during a period when your body is already adjusting to a new medicine. That adjustment period matters: taking berberine while on Wegovy requires exactly the kind of individual clinical assessment that a good prescriber will carry out. The timing questions around berberine and Wegovy are worth working through properly, because starting a supplement at the wrong point in your treatment can mask what is and isn't working.
One thing our clinical team at nume (sorry, at nume) hear regularly: people feel slightly embarrassed asking about supplements because they worry it sounds unserious. It doesn't. It's exactly the kind of detail that changes a clinical recommendation, and a good prescriber wants to know.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.